CryoLife
This article was originally published in The Gray Sheet
Executive Summary
Class action lawsuit filed July 8 in Georgia federal court by Little Rock law firm of Cauley, Geller, Bowman & Coates, LLP on behalf of shareholders who bought CryoLife stock between Aug. 11, 2000 and June 26, 2002 alleges the firm misled investors by purporting compliance with FDA regulations. CryoLife received a warning letter from FDA June 17 citing a number of validation deficiencies at its Kennesaw, Georgia facility (1"The Gray Sheet" July 1, 2002, p. 10)...
You may also be interested in...
CryoLife Reviewing Tissue Sterilization Process In Wake Of Warning Letter
FDA is increasing its scrutiny over validation of tissue processing practices, as evidenced by a June 17 warning letter to CryoLife
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.